2023
Impact of New‐Onset Conduction Disturbances following Transcatheter Aortic Valve Replacement on Outcomes: A Single‐Center Study
See C, Wang Y, Huang H, Parise H, Yang Y, Tirziu D, Francese D, Papoutsidakis N, Bader E, Kaple R, Cleman M, Lansky A, Forrest J. Impact of New‐Onset Conduction Disturbances following Transcatheter Aortic Valve Replacement on Outcomes: A Single‐Center Study. Journal Of Interventional Cardiology 2023, 2023: 5390338. PMID: 37292113, PMCID: PMC10247319, DOI: 10.1155/2023/5390338.Peer-Reviewed Original ResearchMeSH KeywordsAortic ValveAortic Valve StenosisHumansRetrospective StudiesRisk FactorsTranscatheter Aortic Valve ReplacementTreatment OutcomeConceptsTranscatheter aortic valve replacementNew-onset conduction disturbancesAortic valve replacementPersistent conduction disturbancesConduction disturbancesValve replacementSurgical aortic valve replacementSingle-center retrospective analysisYale-New Haven HospitalSingle-center studyCause mortality ratesCause mortality riskLong-term outcomesNew Haven HospitalPeriprocedural factorsAortic stenosisConsecutive patientsTAVR proceduresTerm outcomesRetrospective analysisMortality riskMortality ratePatientsOutcomesPatient's ECGColchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial
Shah T, McCarthy M, Nasir I, Archer H, Ragheb E, Kluger J, Kashyap N, Paredes C, Patel P, Lu J, Kandel P, Song C, Khan M, Huang H, Haq F, Ahmad R, Howes C, Cambi B, Lancaster G, Cleman M, Dela Cruz C, Parise H, Lansky A. Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial. BMJ Open 2023, 13: e067910. PMID: 36828654, PMCID: PMC9971831, DOI: 10.1136/bmjopen-2022-067910.Peer-Reviewed Original ResearchMeSH KeywordsBrain IschemiaColchicineCOVID-19FemaleHumansMaleMiddle AgedRosuvastatin CalciumSARS-CoV-2StrokeTreatment OutcomeConceptsStandard of careHigh-intensity rosuvastatinElectronic medical recordsCOVID-19 diseaseMedical recordsPrimary endpointThromboembolic eventsYale New Haven Health SystemSevere COVID-19 diseaseCOVID-19Prespecified primary endpointVenous thromboembolic eventsRisk of progressionCombination of colchicineSafety monitoring boardCare armHispanics/LatinosTherapeutic anticoagulationIndex hospitalisationIll patientsMedian ageFuture trialsEffect of colchicineClinical trialsMonitoring board
2016
Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006–2011)
Arora S, Panaich SS, Patel N, Patel NJ, Lahewala S, Thakkar B, Savani C, Jhamnani S, Singh V, Patel N, Patel S, Sonani R, Patel A, Tripathi B, Deshmukh A, Chothani A, Patel J, Bhatt P, Mohamad T, Remetz MS, Curtis JP, Attaran RR, Mena CI, Schreiber T, Grines C, Cleman M, Forrest JK, Badheka AO. Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006–2011). Catheterization And Cardiovascular Interventions 2016, 88: 605-616. PMID: 26914274, DOI: 10.1002/ccd.26452.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAmputation, SurgicalCross-Sectional StudiesDatabases, FactualDrug CostsEndovascular ProceduresFemaleHospital CostsHospital MortalityHumansLimb SalvageLogistic ModelsLower ExtremityMaleMiddle AgedMultivariate AnalysisOdds RatioPeripheral Arterial DiseasePlatelet Aggregation InhibitorsPlatelet Glycoprotein GPIIb-IIIa ComplexPropensity ScoreRisk FactorsTime FactorsTreatment OutcomeUnited StatesYoung AdultConceptsGlycoprotein IIb/IIIa inhibitorsPeripheral endovascular interventionsHospital mortalityHospitalization costsEndovascular interventionGPI useAmputation rateUtilization Project Nationwide Inpatient Sample databaseTwo-level hierarchical multivariateIIb/IIIa inhibitorsNationwide Inpatient Sample databaseLower amputation ratesPaucity of dataHospital outcomesPostprocedural complicationsSecondary outcomesPropensity matchingStudy cohortHealthcare costsICD-9Multivariate analysisStudy outcomesSample databaseMortalityHierarchical multivariate
2001
Fractional Flow Reserve Compared With Intravascular Ultrasound Guidance for Optimizing Stent Deployment
Fearon W, Luna J, Samady H, Powers E, Feldman T, Dib N, Tuzcu E, Cleman M, Chou T, Cohen D, Ragosta M, Takagi A, Jeremias A, Fitzgerald P, Yeung A, Kern M, Yock P. Fractional Flow Reserve Compared With Intravascular Ultrasound Guidance for Optimizing Stent Deployment. Circulation 2001, 104: 1917-1922. PMID: 11602494, DOI: 10.1161/hc4101.097539.Peer-Reviewed Original ResearchAdenosineAngioplasty, Balloon, CoronaryBlood Flow VelocityBlood Vessel Prosthesis ImplantationCoronary AngiographyCoronary Artery DiseaseCoronary CirculationCoronary VesselsFemaleHumansLikelihood FunctionsMaleMiddle AgedPredictive Value of TestsProspective StudiesROC CurveSensitivity and SpecificityStentsTreatment OutcomeUltrasonography, Interventional
2000
Final Results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) Study
Fitzgerald P, Oshima A, Hayase M, Metz J, Bailey S, Baim D, Cleman M, Deutsch E, Diver D, Leon M, Moses J, Oesterle S, Overlie P, Pepine C, Safian R, Shani J, Simonton C, Smalling R, Teirstein P, Zidar J, Yeung A, Kuntz R, Yock P, Investigators F. Final Results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) Study. Circulation 2000, 102: 523-530. PMID: 10920064, DOI: 10.1161/01.cir.102.5.523.Peer-Reviewed Original ResearchConceptsIntravascular ultrasoundQuantitative coronary ultrasoundUltrasound guidanceClinical outcomesStent implantationAngiographic guidanceCoronary ultrasoundStent deploymentLarger minimal lumen diameterStent expansionIVUS-guided groupMinimal lumen diameterQuantitative coronary angiographyMinimal stent areaRoutine ultrasound guidanceVessel revascularizationSurgical therapyCoronary angiographyClinical eventsIndex vesselStent areaRegimen studiesLumen diameterPatientsAngiography
1998
Efficacy of Coronary Stenting Versus Balloon Angioplasty in Small Coronary Arteries fn1fn1This study was supported in part by a grant from Johnson & Johnson Interventional Systems, Inc., Warren, New Jersey.
Savage M, Fischman D, Rake R, Leon M, Schatz R, Penn I, Nobuyoshi M, Moses J, Hirshfeld J, Heuser R, Baim D, Cleman M, Brinker J, Gebhardt S, Goldberg S, Investigators F. Efficacy of Coronary Stenting Versus Balloon Angioplasty in Small Coronary Arteries fn1fn1This study was supported in part by a grant from Johnson & Johnson Interventional Systems, Inc., Warren, New Jersey. Journal Of The American College Of Cardiology 1998, 31: 307-311. PMID: 9462572, DOI: 10.1016/s0735-1097(97)00511-1.Peer-Reviewed Original ResearchMeSH KeywordsAngioplasty, Balloon, CoronaryChi-Square DistributionCohort StudiesCoronary AngiographyCoronary DiseaseCoronary VesselsDisease-Free SurvivalElective Surgical ProceduresEquipment DesignFemaleFollow-Up StudiesHumansLinear ModelsMaleMiddle AgedRecurrenceStentsSurvival RateTreatment OutcomeUnited StatesUnited States Food and Drug AdministrationConceptsElective stent placementBalloon angioplastyCoronary arteryStent placementElective stent implantationJohnson Interventional SystemsPostprocedural lumen diameterPrimary end pointEvent-free survivalClinical event ratesSmall coronary arteriesQuantitative coronary angiographyPalmaz-Schatz stentsAngioplasty groupAngiographic characteristicsCoronary angiographyClinical outcomesNew lesionsProcedural successDiameter stenosisStent groupStent implantationAbrupt closurePatientsAngioplasty
1997
Acute and Long-Term Outcome After Palmaz-Schatz Stenting: Analysis From the New Approaches To Coronary Intervention (NACI) Registry
Carrozza J, Schatz R, George C, Leon M, King S, Hirshfeld J, Curry R, Ivanhoe R, Buchbinder M, Cleman M, Goldberg S, Ricci D, Popma J, Safian R, Baim D, Investigators F. Acute and Long-Term Outcome After Palmaz-Schatz Stenting: Analysis From the New Approaches To Coronary Intervention (NACI) Registry. The American Journal Of Cardiology 1997, 80: 78k-88k. PMID: 9409695, DOI: 10.1016/s0002-9149(97)00767-4.Peer-Reviewed Original ResearchConceptsPalmaz-Schatz stentsStent Restenosis StudyTarget lesion revascularizationCoronary Intervention RegistryRecent myocardial infarctionMinimum lumen diameterMyocardial infarctionLesion revascularizationIntervention RegistryProcedural successCoronary arteryHigh riskHigh incidenceLumen diameterSignificant left main stenosisLeft main coronary arteryQ-wave myocardial infarctionPalmaz-Schatz stentingDe novo lesionsLeft main stenosisSaphenous vein graftsCohort of patientsCongestive heart failureMain coronary arteryNative coronary arteries
1996
Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators.
Mark D, Talley J, Topol E, Bowman L, Lam L, Anderson K, Jollis J, Cleman M, Lee K, Aversano T, Untereker W, Davidson-Ray L, Califf R. Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators. Circulation 1996, 94: 629-35. PMID: 8772681, DOI: 10.1161/01.cir.94.4.629.Peer-Reviewed Original ResearchMeSH KeywordsAbciximabAgedAngioplastyAntibodies, MonoclonalAnticoagulantsAspirinBlood TransfusionCosts and Cost AnalysisDouble-Blind MethodFemaleHeparinHumansImmunoglobulin Fab FragmentsInfusions, IntravenousInjections, IntravenousMaleMiddle AgedMyocardial IschemiaPlatelet Aggregation InhibitorsPlatelet Glycoprotein GPIIb-IIIa ComplexRecurrenceStentsTreatment OutcomeUnited StatesConceptsHigh-risk coronary angioplastyC7E3 FabIschemic eventsCoronary angioplastyInitial hospitalizationPlatelet glycoprotein IIb/IIIa inhibitionGlycoprotein IIb/IIIa inhibitionIIb/IIIa inhibitionAggressive platelet inhibitionBaseline medical costsIschemic end pointsReduced ischemic eventsAcute ischemic eventsCost of therapyEPIC trialMajor bleedingBleeding episodesIschemic complicationsStandard carePlatelet inhibitionHospitalization ratesReceptor antibodiesHospital costsMedical costsMedicare fee
1995
Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: The multicenter U.S. Palmaz-Schatz stent experience
Wong S, Baim D, Schatz R, Teirstein P, King S, Curry R, Heuser R, Ellis S, Cleman M, Overlie P, Hirshfeld J, Walker C, Litvack F, Fish D, Brinker J, Buchbinder M, Goldberg S, Chuang Y, Leon M, Group P. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: The multicenter U.S. Palmaz-Schatz stent experience. Journal Of The American College Of Cardiology 1995, 26: 704-712. PMID: 7642863, DOI: 10.1016/0735-1097(95)00217-r.Peer-Reviewed Original ResearchConceptsSaphenous vein graft lesionsVein graft lesionsGraft lesionsStent implantationDiameter stenosisStent placementActuarial event-free survivalFavorable late clinical outcomeNative coronary artery diseaseSaphenous vein graft angioplastySaphenous vein graft diseaseImproved long-term outcomesMultivariate logistic regression analysisFrequent periprocedural complicationsLate clinical outcomesStandard balloon angioplastyStent placement resultsVein graft angioplastyEvent-free survivalProcedural success rateOverall restenosis rateVein graft diseaseCoronary artery diseaseReference vessel sizeLong-term outcomes
1994
Long-term angiographic and clinical outcome after implantation of a ballon-expandable stent in the native coronary circulation
Savage M, Fischman D, Schatz R, Teirstein P, Leon M, Baim D, Ellis S, Topol E, Hirshfeld J, Cleman M, Buchbinder M, Bailey S, Heuser R, Walker C, Curry R, Gebhardt S, Rake R, Goldberg S, group F. Long-term angiographic and clinical outcome after implantation of a ballon-expandable stent in the native coronary circulation. Journal Of The American College Of Cardiology 1994, 24: 1207-1212. PMID: 7930240, DOI: 10.1016/0735-1097(94)90099-x.Peer-Reviewed Original ResearchConceptsNative coronary circulationAdverse clinical eventsMinimal lumen diameterClinical eventsUntreated lesionsStent implantationLumen diameterRepeat angioplastyClinical outcomesCoronary arteryCoronary circulationMyocardial infarctionEvent-free survival rateFinal minimal lumen diameterSingle Palmaz-Schatz stentsSubsequent adverse clinical eventsInitial angiographic resultsCoronary bypass surgeryNative coronary arteriesCoronary stent implantationFavorable clinical outcomeFollow-up angiographyLower restenosis rateEdge detection programPalmaz-Schatz stentsA Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease
Fischman D, Leon M, Baim D, Schatz R, Savage M, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein P, Fish R, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S. A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease. New England Journal Of Medicine 1994, 331: 496-501. PMID: 8041414, DOI: 10.1056/nejm199408253310802.Peer-Reviewed Original ResearchConceptsStandard balloon angioplastyCoronary stent placementBalloon angioplastyLarger luminal diameterAngioplasty groupProcedural successStent groupLuminal diameterOriginal target lesionRecurrent myocardial ischemiaSymptomatic coronary diseaseCoronary artery diseaseLower ratesLarge immediate increasesCoronary eventsArtery diseaseCoronary angiographyCoronary diseaseStented lesionsClinical outcomesCoronary lesionsRandomized comparisonClinical eventsCoronary stenosisStent placement
1992
Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Initial results of a multicenter experience.
Ellis S, Savage M, Fischman D, Baim D, Leon M, Goldberg S, Hirshfeld J, Cleman M, Teirstein P, Walker C. Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Initial results of a multicenter experience. Circulation 1992, 86: 1836-1844. PMID: 1451256, DOI: 10.1161/01.cir.86.6.1836.Peer-Reviewed Original ResearchMeSH KeywordsCoronary AngiographyCoronary DiseaseCoronary VesselsFollow-Up StudiesHumansMaleMiddle AgedRecurrenceStentsTreatment OutcomeConceptsNative coronary arteriesIncidence of restenosisPalmaz-Schatz stentsHistory of restenosisCoronary arteryStent placementMultiple stentsSingle stentPoor long-term resultsQuantitative angiographic dataStandard coronary angioplastyExcellent angiographic resultsLong-term resultsSuccessful stent placementMultiple overlapping stentsPrior restenosisStent closureBaseline characteristicsMulticenter experienceConsecutive patientsCoronary angioplastySuch patientsAngiographic resultsOverall incidenceRandomized trials